1 active not recruiting. 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 1 | Active not recruiting 1 |
Follow COMPASS Pathways: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Efficacy, Safety, and Tolerability of Two Administrations of COMP360 in Participants With TRD Psilocybin - Treatment Resistant Depression | Phase 3 | Active not recruiting | COMPASS Pathways | 572 | 2023-02-14 | 2026-08-10 |
Depressive Disorder, Treatment-Resistant (1)
Psilocybin (1)
Canada (1) · Czechia (1) · Denmark (1) · France (1) · Germany (1) · Ireland (1) · Netherlands (1) · Poland (1) · Spain (1) · Sweden (1) · United Kingdom (1) · United States (1)